An Oncotropic Adenovirus Vector System for Breast Cancer Treatment

Abstract

In this study, we generated the replicating Ad5-based vector encoding the Ad4l short fiber devoid of CAR and HSG binding while containing C-terminal His tag for targeting purposes. We compared our Ad5F4ls6H vector with control Ad5F4ls for the ability to induce cytopathic effect in CAR-positive 293 cells. We found that the parental 293 cells were relatively refractory to Ad5F4ls6H while it was significantly more infectious in 293AR cells, expressing the cognate artificial anti-His tag receptor, as compared to the control Ad5F4ls vector. These results suggest that generated Ad5F4ls6H indeed lacks CAR-mediated tropism while is able to utilize fiber-incorporated His tag for cell binding. In parallel, we produced bispecific 3D5-C6.5 scFv molecule with affinities for both His tag and c-erbB-2 oncoprotein. We then examined the utility of the 3D5-C6.5 adapter for Ad5F4ls6H vector targeting by assessing the improvements in oncolysis of c-erbB-2-positive cells. The presence of the c-erbB-2-targeting 3D5-C6.5 adapter in the infection medium significantly improved the oncolytic potency of the AdSF4ls6H vector in c-erbB-2-positive 435.eBl breast cancer cells. These results indicated that the 3D5-C6.5 adapter mediated specific Ad5F4ls6H binding to the cellular c-erbB-2-oncoprotein allowing efficient oncolytic infection and, thus, demonstrated the feasibility of our Ad targeting approach in vitro.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Sep 01, 2004
Accession Number
ADA430028

Entities

People

  • Igor P. Dmitriev

Organizations

  • University of Alabama

Tags

DTIC Thesaurus Topics

  • Adenoviruses
  • Biomedical Research
  • Breast Cancer
  • Cell Line
  • Cells
  • Chemistry
  • Epithelial Cells
  • Indicator Dyes
  • Infection
  • Medical Personnel
  • Molecules
  • Neoplasms
  • Proteins
  • Targeting
  • Virion
  • Viruses
  • Wound Infections

Fields of Study

  • Biology

Readers

  • Molecular Biology and Genetics
  • Oncology (Cancer Research).